The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review.
about
Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.Prolinamide derivatives as thrombin inhibitors for the treatment of thrombin-mediated diseases: a patent evaluation of US2013296245.Unleashing the therapeutic potential of human kallikrein-related serine proteases.
P2860
The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The emergence of factor Xa inh ...... lar diseases: a patent review.
@en
type
label
The emergence of factor Xa inh ...... lar diseases: a patent review.
@en
prefLabel
The emergence of factor Xa inh ...... lar diseases: a patent review.
@en
P2093
P2860
P1476
The emergence of factor Xa inh ...... lar diseases: a patent review.
@en
P2093
Donald J P Pinto
Jennifer X Qiao
Robert M Knabb
P2860
P304
P356
10.1517/13543776.2012.680438
P407
P577
2012-06-03T00:00:00Z